Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 334Erstellt: 24. Oktober 2026

1-(Benzyloxy)-4-bromo-2-fluorobenzene → (R)-4-(benzyloxy)-N-(2-(tert-butyldimethylsilyloxy)propyl)-3-fluoroaniline

https://huagongshe.com/de/reaction/334

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt1-(Benzyloxy)-4-bromo-2-fluorobenzeneHCID 18757491—
Edukt(R)-2-(tert-butyldimethylsilyloxy)propan-1-amineHCID 59302513—
ReagenzCesium carbonateHCID 10796—
KatalysatorPalladium (II) acetateHCID 4144353—
Katalysator2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
LösungsmittelTolueneHCID 1140—
Produkt(R)-4-(benzyloxy)-N-(2-(tert-butyldimethylsilyloxy)propyl)-3-fluoroanilineHCID 5846443564,8%

Reaktionsbedingungen

Temperatur120 °C

Reaktionsschritte

PdOAc2 (0.799 g, 3.56 mmol) and dicyclohexyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine (1.696 g, 3.56 mmol) were added in one portion to a degassed solution of 1-(benzyloxy)-4-bromo-2-fluorobenzene (10.00 g, 35.57 mmol), (R)-2-(tert- butyldimethylsilyloxy)propan-1-amine (8.08 g, 42.69 mmol) and cesium carbonate (17.39 g, 53.36 mmol) in toluene (150 mL) at 120°C under nitrogen. The resulting suspension was stirred at 120 °C for 16 hours. The reaction was incomplete so the reaction mixture was stirred for a further 24 hours at 120°C. The reaction mixture was diluted with EtOAc (150 mL) and water (150 mL). The biphasic mixture was filtered through celite. The organic layer was separated and washed sequentially with water (150 mL) and saturated brine (150 mL). The organic layer was filtered and dried over Na2SO4, filtered and evaporated to afford crude product. The crude product was evaporated and was purified by flash silica chromatography, elution gradient 0 to 20% EtOAc in isohexane. Pure fractions were evaporated to dryness to afford (R)-4-(benzyloxy)-N-(2-(tert-butyldimethylsilyloxy)propyl)-3-fluoroaniline (8.98 g, 64.8 %) as a orange oil.

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-611f7690ba1449b3a297ce2aee3500c7
Quellennotiz750 AstraZeneca ELN dataset